Alpha-1 Biologics Email Format
Biotechnology ResearchNew York, United States2-10 Employees
Alpha-1 Biologics is a biotechnology research company focused on developing biotherapeutics for cancers and immune deficiencies. It centers on enabling the body's immune system to generate cells from stem cells to treat immunodeficiency and support cancer therapies. Ongoing work includes orally administered small molecules aimed at raising tumor-infiltrating CD4+ T cells and coordinating with immune checkpoint inhibitors to help eliminate tumors, with foundational discoveries stemming from Dr. Bristow's basic research and IHGB. Based in Stony Brook, New York, the company operates as a small biotechnology firm. Its focus lies in the biotechnology research space, emphasizing immune cell generation from stem cells and related immunotherapies. Its patient focus includes individuals with cancer and immune deficiencies, reflecting the diseases the company seeks to address through its research.